Attenuation of neointima formation through the inhibition of DNA repair enzyme PARP-1 in balloon-injured rat carotid artery

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 287, Issue 2 56-2, 2004, Pages

  Zhang, Chunxiang ^a   Yang, Jian ^a   Jennings, Lisa K ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Angioplasty; DNA damage; Oxidative stress; Restenosis

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; DNA; N (5,6 DIHYDRO 6 OXO 2 PHENANTHRIDINYL) 2 DIMETHYLAMINOACETAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANGIOPLASTY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY INJURY; CELL INFILTRATION; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; ENZYME INHIBITION; ENZYME LOCALIZATION; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RESTENOSIS; VASCULAR ENDOTHELIUM;

ANIMALS; BALLOON DILATATION; BIOLOGICAL AVAILABILITY; CAROTID ARTERY INJURIES; DNA DAMAGE; DNA REPAIR; ENDOTHELIUM, VASCULAR; ISOENZYMES; LEUKOCYTES; NITRIC OXIDE; OXIDATIVE STRESS; PHENANTHRENES; POLY(ADP-RIBOSE) POLYMERASES; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; TUNICA INTIMA;

EID: 3042695802     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00162.2004     Document Type: Article

References (49)

1. Azevedo LC, Pedro MA, Souza LC, de Souza HP, Janiszewski M, da Luz PL, and Laurindo FR. Oxidative stress as a signaling mechanism of the vascular response to injury: the redox hypothesis of restenosis. Cardiovasc Res 47: 436-445, 2000.
2. Ballinger SW, Patterson C, Yan CN, Doan R, Burow DL, Young CG, Yakes FM, Van Houten B, Ballinger CA, Freeman BA, and Runge MS. Hydrogen peroxide- and peroxynitrite-induced mitochondrial DNA damage and dysfunction in vascular endothelial and smooth muscle cells. Circ Res 86: 960-966, 2000.
3. Beckman KB and Ames BN. Oxidative decay of DNA. J Biol Chem 272: 19633-19636, 1997.
4. Botto N, Rizza A, Colombo MG, Mazzone AM, Manfredi S, Masetti S, Clerico A, Biagini A, and Andreassi MG. Evidence for DNA damage in patients with coronary artery disease. Mutat Res 493: 23-30, 2001.
5. Burkle A. Physiology and pathophysiology of poly(ADP-ribosyl)ation. Bioessays 23: 795-806, 2001.
6. Cadet J, Douki T, Gasparutto D, and Ravanat JL. Oxidative damage to DNA: formation, measurement and biochemical features. Mutat Res 531: 5-23, 2003.
7. Chen SJ, Li H, Durand J, Oparil S, and Chen YF. Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery, Circulation 93: 577-584, 1996.
8. Cooke MS, Evans MD, Dizdaroglu M, and Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 17: 1195-1214, 2003.
9. Croteau DL and Bohr VA. Repair of oxidative damage to nuclear and mitochondrial DNA in mammalian cells. J Biol Chem 272: 25409-25412, 1997.
10. De Flora S, Izzotti A, Walsh D, Degan P, Petrilli GL, and Lewtas J. Molecular epidemiology of atherosclerosis. FASEB J 11: 1021-1031, 1997.
11. Decker P and Muller S. Modulating poly (ADP-ribose) polymerase activity: potential for the prevention and therapy of pathogenic situations involving DNA damage and oxidative stress. Curr Pharm Biotechnol 3: 275-283, 2002.
12. Eliasson MJ, Sampei K, Mandir AS, Hurn PD, Traystman RJ, Bao J, Pieper A, Wang ZQ, Dawson TM, Snyder SH, and Dawson VL. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat Med 3: 1089-1095, 1997.
13. Frosina G. Overexpression of enzymes that repair endogenous damage to DNA. Eur J Biochem 267: 2135-2149, 2000.
14. Giugliano D, Ceriello A, and Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 19: 257-267, 1996.
15. Griendling KK and FitzGerald GA. Oxidative stress and cardiovascular injury: part I: basic mechanisms and in vivo monitoring of ROS. Circulation 108: 1912-1916, 2003.
16. Harrison D, Griendling KK, Landmesser U, Hornig B, and Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol 91: 7A-11A, 2003.
17. Hasko G, Mabley JG, Nemeth ZH, Pacher P, Deitch EA, and Szabo C. Poly(ADP-ribose) polymerase is a regulator of chemokine production: relevance for the pathogenesis of shock and inflammation. Mol Med 8: 283-289, 2002.
18. Irani K. Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxgen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res 87: 179-183, 2000.
19. Ishizuka S, Martin K, Booth C, Potten CS, de Murcia G, Burkle A, and Kirkwood TB. Poly(ADP-ribose) polymerase-1 is a survival factor for radiation-exposed intestinal epithelial stem cells in vivo. Nucleic Acids Res 31: 6198-6205, 2003.
20. Kunsch C and Medford RM. Oxidative stress as a regulator of gene expression on the vasculature. Circ Res 85: 753-766, 1999.
21. Lacza Z, Horvath EM, Komjati K, Hortobagyi T, Szabo C, and Busija DW. PARP inhibition improves the effectiveness of neural stem cell transplantation in experimental brain trauma. Int J Mol Med 12: 153-159, 2003.
22. Liaudet L, Szabo E, Timashpolsky L, Virag L, Cziraki A, and Szabo C. Suppression of poly (ADP-ribose) polymerase activation by 3-amino-benzamide in a rat model of myocardial infarction: long-term morphological and functional consequences. Br J Pharmacol 133: 1424-1430, 2001.
23. Lidahl T and Wood RD. Quality control by DNA repair. Science 284: 1897-1905, 1999.
24. Mabley JG, Jagtap P, Perretti M, Getting SJ, Salzman AL, Virag L, Szabo E, Soriano FG, Liaudet L, Abdelkarim GE, Hasko G, Marton A, Southan GJ, and Szabo C. Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase. Inflamm Res 50: 561-569, 2001.
25. Martin DR, Lewington AJ, Hammerman MR, and Padanilam BJ. Inhibition of poly(ADP-ribose) polymerase attenuates ischemic renal injury in rats. Am J Physiol Regul Integr Comp Physiol 279: R1834-R1840, 2000.
26. Martinet W, Knaapen MW, De Meyer GR, Herman AG, and Kockx MM. Oxidative DNA damage and repair in experimental atherosclerosis are reversed by dietary lipid lowering. Circ Res 88: 733-739, 2001.
27. Martinet W, Knaapen MW, De Meyer GR, Herman AG, and Kockx MM. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 106: 927-932, 2002.
28. Meagher E and Rader DJ. Antioxidant therapy and atherosclerosis: animal and human studies. Trends Cardiovasc Med 11: 162-165, 2001.
29. Pacher P, Mabley JG, Soriano FG, Liaudet L, and Szabo C. Activation of poly(ADP-ribose) polymerase contributes to the endothelial dysfunction associated with hypertension and aging. Int J Mol Med 9: 659-664, 2002.
30. Pieper AA, Brat DJ, Krug DK, Watkins CC, Gupta A, Blackshaw S, Verma A, Wang ZQ, and Snyder SH. Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes. Proc Natl Acad Sci USA 96: 3059-3064, 1999.
31. Pieper AA, Wailes T, Wei G, Clements EE, Verma A, Snyder SH, and Zweier JL. Myocardial postischemic injury is reduced by polyADPripose polymerase-1 gene disruption. Mol Med 6: 271-282, 2000.
32. Poulsen HE, Jensen BR, Weimann A, Jensen SA, Sorensen M, and Loft S. Antioxidants, DNA damage and gene expression. Free Radic Res 33, Suppl: S33-S39, 2000.
33. Rajagopal V and Rockson SG. Coronary restenosis: a review of mechanisms and management. Am J Med 115: 547-553, 2003.
34. Religa P, Bojakowski K, Maksymowicz M, Bojakowska M, Sirsjo A, Gaciong Z, Olszewski W, Hedin U, and Thyberg J. Smooth-muscle progenitor cells of bone marrow origin contribute to the development of neointimal thickenings in rat aortic allografts and injured rat carotid arteries. Transplantation 74: 1310-1315, 2002.
35. Salonen JT. Clinical trials testing cardiovascular benefits of antioxidant supplementation. Free Radic Res 36:1299-1306, 2002.
36. Soriano FG, Virag L, Jagtap P, Szabo E, Mabley JG, Liaudet L, Marton A, Hoyt DG, Murthy KG, Salzman AL, Southan GJ, and Szabo C. Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat Med 7: 108-113, 2001.
37. Southan GJ and Szabo C. Poly(ADP-ribose) polymerase inhibitors. Curr Med Chem 10: 321-340, 2003.
38. Szabo C. PARP as a drug target for the therapy of diabetic cardiovascular dysfunction. Drug News Perspect 15: 197-205, 2002.
39. Szabo G, Bahrle S, Stumpf N, Sonnenberg K, Szabo EE, Pacher P, Csont T, Schulz R, Dengler TJ, Liaudet L, Jagtap PG, Southan GJ, Vahl CF, Hagl S, and Szabo C. Poly(ADP-ribose) polymerase inhibition reduces reperfusion injury after heart transplantation. Circ Res 90: 100-106, 2002.
40. Szocs K, Lassegue B, Sorescu D, Hilenski LL, Valppu L, Couse TL, Wilcox JN, Quinn MT, Lambeth JD, and Griendling KK. Upregulation of Nox-based NAD(P)H oxidases in restenosis after carotid injury. Arterioscler Thromb Vasc Biol 22: 21-27, 2002.
41. Virag L and Szabo C. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev 54: 375-429, 2002.
42. Wang D, Kreutzer DA, and Essigmann JM. Mutagenicity and repair of oxidative DNA damage: insights from studies using defined lesions. Mutat Res 400: 99-115, 1998.
43. Werner N, Junk S, Laufs U, Link A, Walenta K, Bohm M, and Nickenig G. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 93: e17-e24, 2003.
44. Werner N, Priller J, Laufs U, Endres M, Bohm M, Dirnagl U, and Nickenig G. Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol 22: 1567-1572, 2002.
45. Zalba G, San Jose G, Moreno MU, Fortuno MA, Fortuno A, Beaumont FJ, and Diez J. Oxidative stress in arterial hypertension: role of NAD(P)H oxidase. Hypertension 38: 1395-1399, 2001.
46. Zhang C, Patel R, Eiserich JP, Zhou F, Kelpke S, Ma W, Parks DA, Darley-Usmar V, and White CR. Endothelial dysfunction is induced by proinflammatory, oxidant hypochlorous acid. Am J Physiol Heart Circ Physiol 281: H1469-H1475, 2001.
47. Zhang C, Reiter C, Eiserich JP, Boersma B, Parks DA, Beckman JS, Barnes S, Kirk M, Baidus S, Darley-Usmar VM, and White CR. L-Arginine chlorination products inhibit endothelial nitric oxide production. J Biol Chem 276: 27159-27165, 2001.
48. Zhang C, Yang J, Feng J, and Jennings LK. Short-term administration of basic fibroblast growth factor enhances coronary collateral development without exacerbating atherosclerosis and balloon injury-induced vasoproliferation in atherosclerotic rabbits with acute myocardial infarction. J Lab Clin Med 140: 119-125, 2002.
49. Zhang C, Yang J, Jacobs JD, and Jennings LK. Interaction of MPO with vascular NAD(P)H oxidases derived ROS in the vascular wall and its roles in vascular diseases. Am J Physiol Heart Circ Physiol 285: H2563-H2572, 2003.